Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

12.5%

3 terminated/withdrawn out of 24 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

56%

10 of 18 completed trials have results

Key Signals

2 recruiting10 with results

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (24)

Showing 20 of 24 trials
NCT02146950Active Not Recruiting

European Active Surveillance Study of LCS12

Role: lead

NCT06186271Recruiting

International Active Surveillance Study: Safety of Estrogen Estetrol (E4) Contraceptive Study (INAS-SEECS)

Role: lead

NCT06028555Recruiting

International Active Surveillance Study: Native Estrogen Estetrol (E4) Safety Study

Role: lead

NCT02828904Completed

RIVET - Retrospective Cohort Study on the Risk of Venous Thromboembolism

Role: lead

NCT05186779Terminated

Maternal and Newborn Safety Profile of Progestogens in EARLY Pregnancy

Role: lead

NCT02494297Completed

DUS on the Prescribing Indications for CPA/EE in 5 European Countries

Role: lead

NCT01650168Completed

Prospective Controlled Cohort Study on the Safety of a Monophasic Oral Contraceptive Containing Nomegestrol Acetate (2.5mg) and 17ß-estradiol (1.5mg)

Role: lead

NCT02577913Terminated

European Active Surveillance Study Comparing Regimens of Administration in Combined Hormonal Contraception

Role: lead

NCT04065464Completed

TRACY - Track My Cycle

Role: lead

NCT01266421Completed

Visanne Post-approval Observational Study (VIPOS)

Role: lead

NCT01266408Completed

INAS-FOCUS (International Active Surveillance Study - Folate in Oral Contraceptives Utilization Study)

Role: lead

NCT01473641Completed

Nexplanon Observational Risk Assessment Study (NORA)

Role: lead

NCT00335257Completed

International Active Surveillance Study of Women Taking Oral Contraceptives (INAS-OC)

Role: lead

NCT01009684Completed

International Active Surveillance Study - Safety of Contraceptives: Role of Estrogens

Role: lead

NCT00461253Completed

Case-Control-Study on the Breast Cancer Risk of Mirena® Compared With Copper IUDs

Role: lead

NCT00461175Completed

European Active Surveillance Study for Intrauterine Devices

Role: lead

NCT00551785Terminated

Surveillance Study of Women Taking Intrinsa®

Role: lead

NCT00214903Completed

European Active Surveillance Study of Women Taking Hormone Replacement Therapy (HRT)

Role: lead

NCT00676065Completed

Long-term Active Surveillance Study for Oral Contraceptives (LASS)

Role: lead

NCT00524771Completed

Transatlantic Active Surveillance on Cardiovascular Safety of NuvaRing (TASC)

Role: lead